07 Jan 2001

Albothyl® Vaginalkugeln (Albothyl® Vaginalkugeln) - Deutschland

Updated: 07 Jan 2001

Albothyl® Vaginalkugeln

Lokale Behdlg. von zervikovaginalen Entzündungen bzw. Infektionen u. Gewebsdefekten (z. B. Fluor vaginalis u. zervikalis infolge von Bakterien, Trichomonaden u. Soor, Vaginitis, Cervicitis, Druckgeschwüren bei Pessarträgerinnen) sowie von Feigwarzen u. ä. Behdlg. in den Touchierungsintervallen, wenn eine Touchierung mit Albothyl Konzentrat vorausgegangen ist.

Albothyl® Vaginalkugeln Description, Presentation and Dosage

Albothyl® Vaginalkugeln Description

Albothyl® Vaginalkugeln Drug Class Description

Andere Antiseptika

Albothyl® Vaginalkugeln Drug Description

1 Vaginalkugel enth.: Policresulen 90 mg.

Albothyl® Vaginalkugeln Generic Name

Albothyl® Vaginalkugeln

Albothyl® Vaginalkugeln Presentation

Albothyl® Vaginalkugeln Presentation

Albothyl® Vaginalkugeln

Albothyl® Vaginalkugeln Manufacturer

Byk Gulden

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Albothyl® Vaginalkugeln Dosage

Albothyl® Vaginalkugeln Adult Dosage

Macrogol 1500 u. 4000.

Albothyl® Vaginalkugeln Precautions, Reactions and Contraindications

Albothyl® Vaginalkugeln Special Precautions

Albothyl® Vaginalkugeln Adverse Reactions

Albothyl® Vaginalkugeln Adverse Reactions

Strenge Ind.-Stellung Gr 4 .

Related Drugs - Women's Health and Obs/Gyn

Back to top